"Stomatitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.
| Descriptor ID |
D013280
|
| MeSH Number(s) |
C07.465.864
|
| Concept/Terms |
Oral Mucositis- Oral Mucositis
- Mucositides, Oral
- Oral Mucositides
- Oromucositis
- Oromucositides
- Mucositis, Oral
|
Below are MeSH descriptors whose meaning is more general than "Stomatitis".
Below are MeSH descriptors whose meaning is more specific than "Stomatitis".
This graph shows the total number of publications written about "Stomatitis" by people in this website by year, and whether "Stomatitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Stomatitis" by people in Profiles.
-
Yaroslavsky AN, Iorizzo TW, Juliano AF, Adnan A, Carroll JD, Sonis ST, Duncan CN, London WB, Treister NS. Monte Carlo based dosimetry of extraoral photobiomodulation for prevention of oral mucositis. Sci Rep. 2023 11 22; 13(1):20425.
-
Hari P, Aljitawi OS, Arce-Lara C, Nath R, Callander N, Bhat G, Allen LF, Stockerl-Goldstein K. A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation. Biol Blood Marrow Transplant. 2015 Dec; 21(12):2100-2105.
-
Schwartzberg LS, Tauer KW, Hermann RC, Makari-Judson G, Isaacs C, Beck JT, Kaklamani V, Stepanski EJ, Rugo HS, Wang W, Bell-McGuinn K, Kirshner JJ, Eisenberg P, Emanuelson R, Keaton M, Levine E, Medgyesy DC, Qamar R, Starr A, Ro SK, Lokker NA, Hudis CA. Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab. Clin Cancer Res. 2013 May 15; 19(10):2745-54.
-
Syed EH, Melkonian S, Poudel KC, Yasuoka J, Otsuka K, Ahmed A, Islam T, Parvez F, Slavkovich V, Graziano JH, Ahsan H, Jimba M. Arsenic exposure and oral cavity lesions in Bangladesh. J Occup Environ Med. 2013 Jan; 55(1):59-66.
-
Singh S, Trivedi AN. Spontaneous reports as evidence of adverse drug reactions. South Med J. 2008 Jan; 101(1):16.
-
Lin A, Jabbari S, Worden FP, Bradford CR, Chepeha DB, Teknos TN, Liao JJ, Nyquist GG, Tsien C, Schipper MJ, Urba S, Wolf GT, Eisbruch A. Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005 Dec 01; 63(5):1413-8.
-
Finberg R, Ertl HC, Shapiro ME. Virus-specific cytolytic cells. Their in vivo function. Surv Immunol Res. 1982; 1(3):248-54.